Note: You are reading this message either because your browser is not standards-compliant, or your browser failed to load our css files.

Newsletter
April 8, 2006
Volume VII, Issue 31
Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com

To OTC Journal Members:
 

Coming Attractions: Looking For High Profile Ideas

We've had some fun selling taking profits on big, streaky runs this year, and it's a theme I plan to embrace for the foreseeable future. Recall I recommended selling TLPE when it streaked up to $.41 in early January as the shorts were squeezed. HDY has streaked a couple of times, and profits were available. KAL appears to want to take a breather- but profits were available in that situation as it traded from $1.03 in November to the $1.70 mark in January.

I am trying to find ideas that have the potential to become front page news, which can equate to big moves. Recent idea Advanced Cellular (OTC BB: ACTC) fits the bill. The company was featured in a front page NY Times article last Fall, and boom: big streaky run from $2 to $3 in one day. 

And then there's Cramer who has been very good to OTC Journal subscribers not once, but twice. If you were around last summer when Cramer recommended GEPT at about $3.25, you should also remember us taking profits at $7 to $8 a couple of days later.

And how about DXCM two weeks ago Monday. Personally, my most profitable trade in a long time. Cramer recommended DXCM two Friday's ago at $20. OTC Journal subscribers had the idea at the end of January at $16. The next Monday we had a double whammy: Cramer's move and the FDA Approval all in the same day. Thank you God. I sold my entire position at about $23 for a whopping short term profit. I hope you did as well.

So, now we've got ACTC with the founder of Geron Corp (NASDAQ: GERN) running the company and NY Times ink. The stock has been trading quite nicely since first featuring it.

It happens all the time in the microcap world. Stocks appear to be dormant and testing your patience. Then boom- a major event happens out of nowhere and the stock rockets as everyone piles in. These events are always selling opportunities.

I have two more ideas coming that could be the subject of major publicity in the future. They both have been already. I love selling into those big streaky moves. Look for a couple of new ideas in the next week or two that might float your boat.

Remember- you should view the OTC Journal as simply a source of ideas. If you like the idea and want to act on it, go in with a plan. I strongly recommend deciding how much you want to commit, and taking a partial position to start. Then, if it goes against you, you can add to the position at lower prices, and reduce the position on surges. Most importantly- decide your yourself if you like the idea.
 

The Market Defies Gravity

 
The objective of the correction is to divorce investors from their hard-earned gains; corrections create enough fear to force you out of stocks at the peak of maximum frustration -- the market bottom. Author: Unknown

During the month of March the DOW, S&P 500, NASDAQ Comp, and Russell 2000 all made multi year highs. The market seems to be defying gravity. Last Fall oil prices and interest rates drove stock prices down. We have $68 Crude Oil, $588 gold, and a 10-Yr Yield at 4.84%, all of which project for rising inflation and a Fed that we believe will be more hawkish than the stock market is currently inclined believe. By all rights, the market should be tanking.

In fact, flush with cash from my DXCM trade, I am holding put options on the NASDAQ proxy stock: QQQQ- This is a bet the market will go down. Until Friday's reversal, I was losing big time on the trade. I have since recouped some of my losses, but I'm still underwater.

Here's a long term look at the price of Crude Oil. It is holding up beautifully above the blue line: the 3x3 displaced average. If it doesn't break convincingly below that line in the next several months, look for $90 to $100 crude, and watch the rest of the market tank.

On the other hand, if Crude rolls over, that will be a precursor to a potential market surge.

Here's a look at the HUI- the index which tracks directly to the price of gold. The over all market is saying inflation is tame through its performance. The price of gold says otherwise. Someone is wrong. 

This long term chart shows a "failed double repo". In my technical view, Gold is going higher. Ultimately, higher commodity prices which include gold and oil are good for a few stocks, but bad for the majority. 

The market could keep powering higher. However, unless the price of oil and gold start to head south, I believe we could be in for a rough summer.

It is time to examine your holdings and set your stop losses. If stocks trade against us for an extended period of time, I want everyone to start thinking this way. 

Set your mental stops. If you're stocks trade down to your stop loss levels, sell them and get out. Ideas are plentiful. Capital is scarce. Keep our capital largely intact for better days if you have to.

Click Here to visit our archive section. You will find my suggested stop loss levels listed at each company.

FYI: My Canadian friends are all raving about Golden Peaks Resources Ltd: CDNX Symbol GL.V. I own a few shares, but know little about the company. If you are looking for a speculative gold play, have a look at that one.
 

Subscribe

Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Subscribe Here

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.

Disclaimer
The OTCjournal.com Newsletter is an independent electronic publication committed to providing our readers with factual information on selected  publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward  maximizing the upside potential for investors while minimizing the downside risk, whenever possible.  Moreover, as detailed below, this publication accepts compensation from certain of the companies which it features.  Likewise, this newsletter is owned by MarketByte, LLC.  To the degrees enumerated herein,  this newsletter should not be regarded as an independent publication.

Go Here to view our compensation on every company we have ever covered, or visit the following web address:  http://www.otcjournal.com/disclaimer.html for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html for Trading Alerts. MarketByte LLC has been paid a fee of $25,000 and 600,000 newly issued restricted shares by Teleplus Inc for coverage of the company.

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities  mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

From time to time MarketByte LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

The editor, members of the editor's family, and/or entities with which they are affiliated aside from MarketBtye LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter. Some of the companies featured in the OTC Journal pay a cash ESP fee to an affiliated technology company ranging from $2,000 to $5,000 per month for internet related technology services.

The Trustee of the MarketByte LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $140,0000 in Dutchess Private Equities II LP (“the Dutchess Limited Partnership”), a limited partnership in which the MarketByte Pension Plan is a limited partner. The Trustee of the MarketByte LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $190,0000 in the Longview Fund (“the Longview Limited Partnership”), both limited partnerships in which the MarketByte Pension Plan is a limited partner. No one associated with the MarketByte Pension Plan has any knowledge, information, or control as to any past, present, or future investment activities of the Dutchess Limited Partnership or the Longview Fund.  The Dutchess Limited Partnership is one of two hedge funds managed by Dutchess Advisors.  Dutchess Advisors and Longview periodically refers companies to MarketByte LLC for possible coverage by one of the MarketByte LLC publications, which publications include The OTCJournal.com Newsletter.  Dutchess Advisors or Longview may or may not own shares in the companies that it so refers to MarketByte. MarketByte has no information (outside of information readily accessible to the general public such as SEC filings) as to whether Dutchess Advisors or Longview owns any shares in the companies that it refers to MarketByte LLC.  The above relationships should be viewed as a potential and/or actual conflict of interest by shareholders and prospective shareholders of MarketByte LLC client companies. 

The profiles, critiques, and other editorial content of the OTCjournal.com may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN  SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN  CONSENT OF THE EDITORS OF OTCjournal.com.

We encourage our readers to invest carefully and read the investor information available at the web sites of  the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at  http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID:$subst('Recip.userid') Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.  MarketByte LLC's mailing address is 3525 Del Mar Heights Rd #334, San Diego, CA 92130.


Unsubscribe Here

You can unsubscribe from this list at any time by Clicking Here and HITTING SEND. If you are having difficulty removing yourself or wish to change your address please go to http://listserv.otcjournal.com/opt.cgi?.

 

Click Here to View the OTC Journal Disclosure

China Energy Recovery, Inc.
Newsletter
Editions
RSS Subscribe

To subscribe to our newsletter, please enter your email address below.

7 Minutes To Wealth
May 12, 2012

Share
Market Summary
Nasdaq 2813.69 -60.35 (-2.10%)
Russell 2K 754.33 -17.78 (-2.30%)
S&P 500 1304.86 -19.94 (-1.51%)
S&P 100 595.89 -7.61 (-1.26%)
Quotes are delayed 20 minutes.

Add to Google

China Stocks and Penny Stocks - Discover Tomorrow's Winners Today

© 2012 OTC Journal